It is a chemicals private limited company based in Agra, Uttar Pradesh, India, established in 2003.
2003 | Agra, Uttar Pradesh, India | ActiveLexica Drugs And Formulations Private Limited, a active private limited company, was established on 05 February 2003 in Agra, Uttar Pradesh, India. Engaging in medicinal chemical & botanical products within the manufacturing sector, it holds CIN: U51397UP2003PTC181762. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Neelu Rani Singh (Director), Digambar Singh (Director). Past directors included Sunil Parmar Kumar. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at C/O Digamber Singh, Kh. No. 737 Sikandrapur 83 Om Re-Bahadur Singh, Agra, Uttar Pradesh, 282009.
U51397UP2003PTC181762
181762
05 February 2003
₹0.10 M
₹0.10 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Lexica Drugs And Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Neelu Rani Singh | Director | 05 Feb 2003 | Current |
| Digambar Singh | Director | 05 Feb 2003 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 16 Jul 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Lexica Drugs And Formulations Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Lexica Drugs And Formulations had a promoter holding of 90.00% and a public holding of 10.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Lexica Drugs And Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Lexica Drugs And Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lexica Drugs And Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Lexica Drugs And Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
The activity Lexica Drugs And Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was completed.
Neelu Rani Singh was appointed as a Director was appointed as a Director on 05 Feb 2003 & has been associated with this company since 22 years 10 months . was recorded as a recent event.
Progress on Digambar Singh was appointed as a Director was appointed as a Director on 05 Feb 2003 & has been associated with this company since 22 years 10 months . was documented.
Progress on Lexica Drugs And Formulations Private Limited was registered on 05 Feb 2003 with Roc Kanpur & aged 22 years 10 months as per MCA records. was documented.
The CIN of Lexica Drugs And Formulations Private Limited is U51397UP2003PTC181762.
Lexica Drugs And Formulations Private Limited is headquartered at C/O Digamber Singh, Kh. No. 737 Sikandrapur 83 Om Re-Bahadur Singh, Agra, Uttar Pradesh, 282009.
Lexica Drugs And Formulations Private Limited was incorporated on 05 February 2003.
The current directors of Lexica Drugs And Formulations Private Limited are
The primary industry of Lexica Drugs And Formulations Private Limited is Manufacturing.
Lexica Drugs And Formulations Private Limited is unlisted.
The authorized capital of Lexica Drugs And Formulations Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Lexica Drugs And Formulations Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX